559 related articles for article (PubMed ID: 14680965)
1. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.
Jaiswal S; Khanna N; Swaminathan S
Protein Expr Purif; 2004 Jan; 33(1):80-91. PubMed ID: 14680965
[TBL] [Abstract][Full Text] [Related]
2. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].
Lu P; Wei Y; Cao SC; Li JD; Liu QZ; Zhang QF; Li C; Miao F; Zhang S; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):177-9. PubMed ID: 19031695
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of recombinant dengue virus type 4 envelope domain III protein.
Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV
J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971
[TBL] [Abstract][Full Text] [Related]
6. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.
Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML
Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950
[TBL] [Abstract][Full Text] [Related]
7. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
[TBL] [Abstract][Full Text] [Related]
8. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
Tripathi NK; Shrivastava A; Biswal KC; Rao PV
Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of recombinant soluble dengue virus 2 envelope domain III protein production in Escherichia coli trxB and gor double mutant.
Saejung W; Puttikhunt C; Prommool T; Sojikul P; Tanaka R; Fujiyama K; Malasit P; Seki T
J Biosci Bioeng; 2006 Oct; 102(4):333-9. PubMed ID: 17116581
[TBL] [Abstract][Full Text] [Related]
10. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
Khanam S; Khanna N; Swaminathan S
Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
[TBL] [Abstract][Full Text] [Related]
12. Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes.
Khanam S; Etemad B; Khanna N; Swaminathan S
Am J Trop Med Hyg; 2006 Feb; 74(2):266-77. PubMed ID: 16474083
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification and evaluation of diagnostic potential and immunogenicity of dengue virus type 3 domain III protein.
Reddy PB; Pattnaik P; Tripathi NK; Srivastava A; Rao PV
Protein Pept Lett; 2012 May; 19(5):509-19. PubMed ID: 22486646
[TBL] [Abstract][Full Text] [Related]
14. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
[TBL] [Abstract][Full Text] [Related]
15. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
[TBL] [Abstract][Full Text] [Related]
17. An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes.
Etemad B; Batra G; Raut R; Dahiya S; Khanam S; Swaminathan S; Khanna N
Am J Trop Med Hyg; 2008 Sep; 79(3):353-63. PubMed ID: 18784226
[TBL] [Abstract][Full Text] [Related]
18. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
19. Production, purification and characterization of recombinant dengue multiepitope protein.
Tripathi NK; Shrivastva A; Pattnaik P; Parida M; Dash PK; Jana AM; Rao PV
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):105-13. PubMed ID: 16999685
[TBL] [Abstract][Full Text] [Related]
20. [Expression and function analysis of dengue virus type 1 to 4 envelope domain III recombinant fusion protein].
Niu GY; Lu P; Zhang S; Zhang QF; Li C; Liang MF; Xu F; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):161-4. PubMed ID: 21186514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
